drugset / Trial / NCT00334022

Fuzeon Viral Decay Pilot Study

NCT00334022

RandomizedParallel-groupOpen-labelTreatment

Summary

In order to better understand the source(s) and the mechanism(s) of HIV persistence and to potentially lead to further suppression of HIV from viral reservoirs, we propose to examine the effect of co-administration of enfuvirtide, an entry inhibitor of HIV, on diminution of the size of the viral reservoir in infected individuals who are receiving effective antiviral therapy for extended periods of time (\> 5 years).

Timeline

Start
2006-02
Primary completion
2007-07
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Enfuvirtide Peptide 1 ml

Indications

No indication recorded.